ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,397, issued on Sept. 30, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).
"Factor XI activation inhibitors" was invented by Jacqueline D. Hicks (Watchung, N.J.), John S. Debenham (Scotch Plains, N.J.), Amjad Ali (Freehold, N.J.), Ying-Duo Gao (Middletown, N.J.), Lan Wei (Berkeley Heights, N.J.), Dexi Yang (Livingston, N.J.), Rongze Kuang (Green Brook, N.J.), Alan Hruza (Hackettstown, N.J.), Peter Nizner (Fanwood, N.J.) and Daniel A. Tatosian (Berkeley Heights, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and ...